We are live on ! Find out more
SBFMW icon

Sunshine Biopharma Warrant
SBFMW

2 hedge funds and large institutions have $6.87K invested in Sunshine Biopharma Warrant in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.94% more ownership

Funds ownership: 0.2% → 2.14% (+1.9%)

0% more funds holding

Funds holding: 2 → 2 (0)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $667

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$574
2
UBS Group
UBS Group
Switzerland
-$93

SBFMW Hedge Fund Activity: Q4 2024 in Review

2 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Warrant (SBFMW) for Q4 2024, worth a combined $6.87K — up 33% from $5.16K a quarter earlier.

Fund positioning in SBFMW was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.

The largest seller was Citadel Advisors, cutting an estimated $574.

  • 2 institutional investors held Sunshine Biopharma Warrant (SBFMW) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $6.87K of Sunshine Biopharma Warrant stock for Q4 2024, up 33% quarter-over-quarter.
  • 0 funds opened new Sunshine Biopharma Warrant positions in Q4 2024 and 0 closed out.
  • The largest Sunshine Biopharma Warrant seller in Q4 2024 was Citadel Advisors, an estimated $574 sold.

Based on aggregated 13F filings for Q4 2024.